Regulation of Interleukin-12 Production in Human Cells Stimulated withMycobacterium bovisBCG
- 10 October 1998
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 189 (1), 25-30
- https://doi.org/10.1006/cimm.1998.1361
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Two inhibitors of pro‐inflammatory cytokine release, interleukin‐10 and interleukin‐4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytesEuropean Journal of Immunology, 1994
- Interleukin 12 at the site of disease in tuberculosis.JCI Insight, 1994
- Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-AnalysisInternational Journal of Epidemiology, 1993
- Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.The Journal of Experimental Medicine, 1993
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.The Journal of Experimental Medicine, 1993
- Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.The Journal of Experimental Medicine, 1992
- Macrophage deactivation by interleukin 10.The Journal of Experimental Medicine, 1991
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991